Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)

NCT00402597 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3490

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Rivaroxaban/Placebo
DRUG: Placebo
DRUG: Rivaroxaban

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]